GSK Unclassified
FDA Approved Drugs
GSK Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 14
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Social Profiles
Company Snapshot
GSK Unclassified
980 Great West Road, Brentford, Middlesex TW8 9GS England
United Kingdom
www.gsk.com:443/en-gb/ View on MapFDA Approved Drug Records ( 14 records )
Drug Name
BENLYSTA
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
-
Active Ingredient
BELIMUMAB
Application Number
761043
Product Number
1
Dosage Form
-
Strength
200MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BLENREP
Product Number
1
Dosage Form
-
Strength
70MG
Approval Date
-
Active Ingredient
BELANTAMAB MAFODOTIN-BLMF
Application Number
761440
Product Number
1
Dosage Form
-
Strength
70MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EXDENSUR
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
DEPEMOKIMAB-ULAA
Application Number
761458
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
JEMPERLI
Product Number
1
Dosage Form
-
Strength
500MG/10ML
Approval Date
-
Active Ingredient
DOSTARLIMAB-GXLY
Application Number
761174
Product Number
1
Dosage Form
-
Strength
500MG/10ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
JEMPERLI
Product Number
1
Dosage Form
-
Strength
500MG/10ML
Approval Date
-
Active Ingredient
DOSTARLIMAB-GXLY
Application Number
761223
Product Number
1
Dosage Form
-
Strength
500MG/10ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMICTAL XR
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
LAMOTRIGINE
Application Number
22509
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMICTAL XR
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
LAMOTRIGINE
Application Number
22509
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMICTAL XR
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
LAMOTRIGINE
Application Number
22509
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMICTAL XR
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
LAMOTRIGINE
Application Number
22509
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUCALA
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
MEPOLIZUMAB
Application Number
125526
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUCALA
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
-
Active Ingredient
MEPOLIZUMAB
Application Number
761122
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
TANZEUM
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
-
Active Ingredient
ALBIGLUTIDE
Application Number
125431
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VALTREX
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
-
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
20550
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VALTREX
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
-
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
20550
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Status Breakdown
14 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
BENLYSTA
Application Number
761043
Product Number
1
Active Ingredient
BELIMUMAB
Dosage Form
-
Strength
200MG/ML
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.